CAS 959841-49-7

(E)-Akt inhibitor-IV

CAS: 959841-49-7

Formel: C₃₂H₃₁IN₄S

Molekulargewicht: 630.5848

Ref: IN-DA01V7C2

(E)-Akt inhibitor-IV

CAS: 959841-49-7

(E)-Akt inhibitor-IV ((E)-AKTIV)  ((E)-AKTIV) is an inhibitor of PI3K-Akt.

Formel: C₃₁H₂₉IN₄S

Reinheit: 99.74% - 99.9%

Farbe und Form: Solid

Molekulargewicht: 616.558

Ref: TM-T9393

(E)-6-(Benzo[d]thiazol-2-yl)-1-ethyl-2-(2-(methyl(phenyl)amino)vinyl)-3-phenyl-1H-benzo[d]imidazol-3-ium iodide

CAS: 959841-49-7

(E)-6-(Benzo[d]thiazol-2-yl)-1-ethyl-2-(2-(methyl(phenyl)amino)vinyl)-3-phenyl-1H-benzo[d]imidazol-3-ium iodide

Formel: C₃₁H₂₇IN₄S

Reinheit: 98%

Molekulargewicht: 614.54

Ref: IN-DG01433126

(E)-Akt inhibitor-IV

CAS: 959841-49-7

(E)-Akt inhibitor-IV is a potent and selective inhibitor of the protein kinase Akt. It has been shown to induce apoptosis in human tumor and Chinese hamster ovary cells. This analog of the Akt inhibitor is known for its anticancer properties, as it effectively inhibits the activity of kinases that promote cancer cell growth. The (E)-Akt inhibitor-IV has been found to be effective in treating various types of cancer, including breast and prostate cancer. Additionally, this inhibitor has been shown to enhance the anticancer effects of vitamin D in vitro. Overall, (E)-Akt inhibitor-IV is a promising therapeutic agent for cancer treatment due to its potent inhibitory effects on Akt activity and induction of apoptosis in cancer cells.

Formel: C₃₁H₂₉IN₄S

Reinheit: Min. 95%

Molekulargewicht: 616.6 g/mol

Ref: 3D-JNB84149